Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: Introducing a vaccination provocation model

Netherlands Journal of Medicine

Volumn 63, Issue 7, 2005, Pages 260-264

  Bodar, E J ^a   van der Hilst, J C H ^a   Drenth, J P H ^a   van der Meer, J W M ^a   Simon, A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anakinra; Etanercept; Hyper IgD syndrome; Interleukin I; Periodic fever; TNF; Vaccination

Indexed keywords

C REACTIVE PROTEIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ETANERCEPT; HEPATITIS A VACCINE; IMMUNOGLOBULIN D; MEVALONATE KINASE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABDOMINAL PAIN; ADULT; APHTHOUS ULCER; ARTHRALGIA; ARTICLE; BLOOD SAMPLING; BODY TEMPERATURE; BORDETELLA PERTUSSIS; CASE REPORT; CLINICAL PROTOCOL; CLOSTRIDIUM TETANI; CONTROLLED STUDY; CORYNEBACTERIUM DIPHTHERIAE; DIARRHEA; DIPHTHERIA; DISEASE SEVERITY; DRUG EFFICACY; FATIGUE; FEMALE; FEVER; GENE MUTATION; HEADACHE; HEPATITIS A; HEPATITIS A VIRUS; HOSPITAL ADMISSION; HUMAN; HYPERIMMUNOGLOBULINEMIA; LYMPHADENOPATHY; MYALGIA; NAUSEA; NOSE CONGESTION; PATIENT MONITORING; PERTUSSIS; PILOT STUDY; PROVOCATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SCORING SYSTEM; SKIN DEFECT; SORE THROAT; SYMPTOM; TETANUS; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; RECEPTORS, TUMOR NECROSIS FACTOR; SIALOGLYCOPROTEINS; VACCINES;

EID: 23844552119     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Drenth JPH, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JWM. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 1995;85:3586-93.
2. Drenth JPH, Haagsma CJ, van der Meer JWM. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 1994;73:133-44.
3. Drenth JPH, Vonk AG, Simon A, Powell R, van der Meer JWM. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 2001;298:1221-6.
4. Simon A, Drewe E, van der Meer JW, et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 2004;75:476-83.
5. Takada K, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL. Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 2003;48:2645-51.
6. Arkwright PD, McDermott MF, Houten SM, et al. Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept. Clin Exp Immunol 2002;130:484-8.
7. Marchetti F, Barbi E, Tommasini A, Oretti C, Ventura A. Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol 2004;22:791-2.
8. Drenth JPH, van der Meer JWM. Hereditary Periodic Fever. N Engl J Med 2001;345:1748-57.
9. Simon A, Bodar EJ, van der Hilst JC et al. Beneficial response to interleukin 1 receptor antagonist in traps. Am J Med 2004;117:208-10.
10. Frenkel J, Wulffraat NM, Kuis W. Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al. and Hoffman and Patel. Arthritis Rheum 2004;50:3738-9.
11. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003;348:2583-4.
12. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607-12.
13. Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology (Oxford) 2005.